AcelRx Pharmaceuticals Reports Q2 Loss, Tops Revenue Estimates
| ACRXDelisted Stock | USD 1.01 0.01 1.00% |
Slightly above 50% of ACRX Old's investors are presently thinking to get in. The analysis of current outlook of investing in ACRX Old suggests that some traders are interested regarding ACRX Old's prospects. ACRX Old's investing sentiment can be driven by a variety of factors including economic data, ACRX Old's earnings reports, geopolitical events, and overall market trends.
ACRX |
AcelRx Pharmaceuticals delivered earnings and revenue surprises of 22.64 percent and 216.25, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
 |
ACRX Old Fundamental Analysis
We analyze ACRX Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACRX Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACRX Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
ACRX Old is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
ACRX Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACRX Old stock to make a market-neutral strategy. Peer analysis of ACRX Old could also be used in its relative valuation, which is a method of valuing ACRX Old by comparing valuation metrics with similar companies.
Peers
ACRX Old Related Equities
| AMRX | Amneal Pharmaceuticals, | 2.41 | ||||
| SHPH | Shuttle Pharmaceuticals | 1.15 | ||||
| ORGO | Organogenesis Holdings | 1.26 | ||||
| LFCR | Lifecore Biomedical | 1.86 | ||||
| EVOK | Evoke Pharma | 2.43 | ||||
| AQST | Aquestive Therapeutics | 2.80 | ||||
| ASRT | Assertio Therapeutics | 3.49 | ||||
| TLRY | Tilray | 5.52 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in ACRX Stock
If you are still planning to invest in ACRX Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACRX Old's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |